Neridronic acid
Neridronic acid is a bisphosphonate medication primarily used in the treatment of osteoporosis and other bone diseases. It is known for its ability to inhibit bone resorption, which is the process by which bone is broken down and its minerals released into the bloodstream.
Mechanism of Action[edit | edit source]
Neridronic acid works by binding to hydroxyapatite found in bone, inhibiting the action of osteoclasts, the cells responsible for bone resorption. This leads to a decrease in bone turnover, helping to maintain or increase bone density and strength.
Medical Uses[edit | edit source]
Neridronic acid is used in the treatment of several conditions, including:
Administration[edit | edit source]
Neridronic acid is typically administered via intravenous infusion. The dosage and frequency of administration depend on the specific condition being treated and the patient's overall health status.
Side Effects[edit | edit source]
Common side effects of neridronic acid include:
Contraindications[edit | edit source]
Neridronic acid should not be used in patients with:
- Severe renal impairment
- Hypersensitivity to bisphosphonates
Pharmacokinetics[edit | edit source]
After intravenous administration, neridronic acid is rapidly distributed to the bone. It has a long half-life due to its strong affinity for bone tissue, which allows for infrequent dosing schedules.
Research and Development[edit | edit source]
Neridronic acid is currently being studied for its potential use in other bone-related conditions and diseases. Ongoing research aims to better understand its efficacy and safety profile in various patient populations.
See Also[edit | edit source]
- Bisphosphonate
- Osteoporosis
- Paget's disease of bone
- Complex Regional Pain Syndrome
- Osteogenesis imperfecta
References[edit | edit source]
External Links[edit | edit source]
Translate: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD